The objective of the Alzheimer's Disease Phase I Clinical Trials initiative is to provide support for first-in-human studies for promising Alzheimers disease therapeutics. These first stage clinical trials will evaluate the metabolic and pharmacological actions of drugs, including biologics in humans.
Funding Number:
RFA-AG-13-016
Office:
DN [2]
Expiration Date:
Tuesday, January 15, 2013
Release Date:
Monday, October 15, 2012